RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 10, Pages 1694
Publisher
MDPI AG
Online
2021-10-18
DOI
10.3390/pharmaceutics13101694
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dendritic Cell-Based Immunotherapy in Lung Cancer
- (2021) Dieter Stevens et al. Frontiers in Immunology
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- RNA-based pharmacotherapy for tumors: From bench to clinic and back
- (2020) Xiangping Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- Proliferation‐associated long noncoding RNA, TMPO‐AS1 , is a potential therapeutic target for triple‐negative breast cancer
- (2020) Yuichi Mitobe et al. CANCER SCIENCE
- A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral (iTu) injection alone and in combination with durvalumab.
- (2020) Manish R. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery
- (2020) Yulia Eygeris et al. NANO LETTERS
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Delivery and Biosafety of Oncolytic Virotherapy
- (2020) Lizhi Li et al. Frontiers in Oncology
- Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer
- (2020) Zhen Zhao et al. Science Advances
- ADAM9 Mediates Triple-Negative Breast Cancer Progression via AKT/NF-κB Pathway
- (2020) Rui Zhou et al. Frontiers in Medicine
- Emerging CAR-T Cell Therapy for the Treatment of Triple Negative Breast Cancer
- (2020) Sundee Dees et al. MOLECULAR CANCER THERAPEUTICS
- Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
- (2020) Ayeskanta Mohanty et al. MOLECULES
- LGR6 Promotes Tumor Proliferation and Metastasis through Wnt/β-Catenin Signaling in Triple-Negative Breast Cancer
- (2020) Yanan Kong et al. Molecular Therapy-Oncolytics
- Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
- (2020) Muhammad Imran Sajid et al. Pharmaceuticals
- COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology
- (2020) Hyun Jee Han et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease
- (2020) Amal Qattan INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
- (2020) Simona Ruxandra Volovat et al. Frontiers in Oncology
- Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells
- (2020) Chi Zhang et al. LIFE SCIENCES
- Recent therapeutic trends and promising targets in triple negative breast cancer
- (2019) Soo-Yeon Hwang et al. PHARMACOLOGY & THERAPEUTICS
- Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
- (2019) Jiangsheng Xu et al. Nature Nanotechnology
- mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
- (2019) Giulietta Maruggi et al. MOLECULAR THERAPY
- Nanoparticle Delivery of miR-708 Mimetic Impairs Breast Cancer Metastasis
- (2019) Divya Ramchandani et al. MOLECULAR CANCER THERAPEUTICS
- Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy
- (2019) Amita M Vaidya et al. BIOCONJUGATE CHEMISTRY
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133
- (2019) Hongran Yin et al. MOLECULAR THERAPY
- Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure‐Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin‐Mediated (hATTR) Amyloidosis
- (2019) Xiaoping Zhang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Carrier-Free CXCR4-Targeted Nanoplexes Designed for Polarizing Macrophages to Suppress Tumor Growth
- (2019) Michael B. Deci et al. Cellular and Molecular Bioengineering
- Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
- (2019) Chunai Gong et al. JOURNAL OF NANOBIOTECHNOLOGY
- A Novel Bioengineered MicroRNA-127 Prodrug Suppresses The Growth And Metastatic Potential Of Triple Negative Breast Cancer Cells
- (2019) Maxine Umeh-Garcia et al. CANCER RESEARCH
- Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
- (2019) Anbarasu Kannan et al. Scientific Reports
- MicroRNAs Contribute to Breast Cancer Invasiveness
- (2019) Ivana Fridrichova et al. Cells
- Designer nanocarriers for navigating the systemic delivery of oncolytic viruses
- (2019) Faith Howard et al. Nanomedicine
- Molecular stratification within triple-negative breast cancer subtypes
- (2019) Dong-Yu Wang et al. Scientific Reports
- Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
- (2018) Emanuela Martino et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival
- (2018) Thomas A. Werfel et al. CANCER RESEARCH
- Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
- (2018) L. Gerratana et al. CANCER TREATMENT REVIEWS
- MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models
- (2018) Zheng Xue et al. CELL RESEARCH
- Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion
- (2018) Recep Bayraktar et al. CLINICAL CANCER RESEARCH
- AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells
- (2018) Diana Rafael et al. DRUG DELIVERY
- MicroRNAs in regulation of triple-negative breast cancer progression
- (2018) Dominika Piasecka et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- Dendritic Cell–Based Cancer Vaccines
- (2018) Patricia M. Santos et al. JOURNAL OF IMMUNOLOGY
- Targeted delivery of CD44s-siRNA by ScFv overcomes de novo resistance to cetuximab in triple negative breast cancer
- (2018) Wenyan Fu et al. MOLECULAR IMMUNOLOGY
- Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
- (2018) Lina Liu et al. MOLECULAR THERAPY
- Liposomal Drug Delivery Systems and Anticancer Drugs
- (2018) Temidayo Olusanya et al. MOLECULES
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer
- (2018) Peijing Zhang et al. Cell Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genetic Markers in Triple-Negative Breast Cancer
- (2018) Zuzana Sporikova et al. Clinical Breast Cancer
- An RNA toolbox for cancer immunotherapy
- (2018) Fernando Pastor et al. NATURE REVIEWS DRUG DISCOVERY
- Extracellular vesicles produced in B cells deliver tumor suppressor miR-335 to breast cancer cells disrupting oncogenic programming in vitro and in vivo
- (2018) Gonzalo Almanza et al. Scientific Reports
- Dysregulation of microRNAs in triple-negative breast cancer
- (2017) Sylwia Paszek et al. Ginekologia Polska
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors
- (2017) Zilan Zhou et al. Nanomedicine-Nanotechnology Biology and Medicine
- Antibody fragments as nanoparticle targeting ligands: a step in the right direction
- (2017) Daniel A. Richards et al. Chemical Science
- Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells
- (2017) KeeSoo Nam et al. Oncotarget
- Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
- (2017) John J. Suschak et al. Human Vaccines & Immunotherapeutics
- Mathematical Modeling: A Tool for Optimization of Lipid Nanoparticle-Mediated Delivery of siRNA
- (2017) Radu Mihaila et al. Molecular Therapy-Nucleic Acids
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Imaging-guided delivery of RNAi for anticancer treatment
- (2016) Junqing Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer
- (2016) Elvira D'Ippolito et al. CANCER RESEARCH
- Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells
- (2016) Manoj B. Parmar et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy
- (2016) Aarohi Bhargava-Shah et al. Nanomedicine
- Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
- (2016) Shengpeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells
- (2016) Hanna Taipaleenmäki et al. Oncotarget
- MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
- (2016) Recep Bayraktar et al. Oncotarget
- ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
- (2016) Peng Guo et al. Theranostics
- Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy
- (2016) Maneesh Gujrati et al. Advanced Healthcare Materials
- 18F-FDG PET/CT for Monitoring the Response of Breast Cancer to miR-143-Based Therapeutics by Targeting Tumor Glycolysis
- (2016) Ying Miao et al. Molecular Therapy-Nucleic Acids
- Combination of microRNA therapeutics with small-molecule anticancer drugs: Mechanism of action and co-delivery nanocarriers
- (2015) Xin Dai et al. ADVANCED DRUG DELIVERY REVIEWS
- Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association
- (2015) Eunjung Lee et al. JOURNAL OF CONTROLLED RELEASE
- Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells
- (2015) SHIHAI LIU et al. ONCOLOGY REPORTS
- miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
- (2015) Keith O’Brien et al. Oncotarget
- RNA-Based Vaccines in Cancer Immunotherapy
- (2015) Megan A. McNamara et al. Journal of Immunology Research
- siRNA Versus miRNA as Therapeutics for Gene Silencing
- (2015) Jenny K W Lam et al. Molecular Therapy-Nucleic Acids
- Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer
- (2014) Xiongwei Deng et al. BIOMATERIALS
- Subtyping of triple-negative breast cancer: Implications for therapy
- (2014) Vandana G. Abramson et al. CANCER
- Polymeric micelles for oral drug administration enabling locoregional and systemic treatments
- (2014) Susana MN Simões et al. Expert Opinion on Drug Delivery
- Systematic review of catalyst nanoparticles synthesized by solution process: towards efficient carbon nanotube growth
- (2014) Mohd Asyadi Azam et al. JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
- Polymeric Micelle Assembly for Preparation of Large-Sized Mesoporous Metal Oxides with Various Compositions
- (2014) Bishnu Prasad Bastakoti et al. LANGMUIR
- Recent developments in the co-delivery of siRNA and small molecule anticancer drugs for cancer treatment
- (2014) Manju Saraswathy et al. Materials Today
- Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy
- (2014) Varun Kumar et al. Molecular Therapy-Nucleic Acids
- Nanoemulsion: an advanced mode of drug delivery system
- (2014) Manjit Jaiswal et al. 3 Biotech
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
- (2013) Luca F. R. Gebert et al. NUCLEIC ACIDS RESEARCH
- Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
- (2013) R. Joseph Bender et al. PLoS One
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- Safety profile of RNAi nanomedicines
- (2012) Scott A. Barros et al. ADVANCED DRUG DELIVERY REVIEWS
- RNA interference in mammals: behind the screen
- (2011) E. Campeau et al. Briefings in Functional Genomics
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Sperm-Derived SPANX-B Is a Clinically Relevant Tumor Antigen That Is Expressed in Human Tumors and Readily Recognized by Human CD4+ and CD8+ T Cells
- (2009) G. Almanzar et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started